The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Tenshi Pharmaceuticals Pvt Ltd & PACs
ONESOURCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Tenshi Pharmaceuticals Pvt Ltd and persons acting in concert (promoter and promoter group) acquired 75,000 equity shares (0.07%) of Onesource Specialty Pharma Ltd through open market purchases on January 30, 2026. Post-acquisition, the promoter group's aggregate holding increased from 30.10% (3,44,96,199 shares) to 30.17% (3,45,71,199 shares) of the company's paid-up equity capital. The total equity share capital of the company remains unchanged at 11,46,21,201 shares of Rs.1 each. This is a routine creeping acquisition disclosure under SEBI Takeover Regulations and reflects continued promoter confidence in the company.
A minor open market purchase by the promoter group signals insider confidence, though the 0.07% increase is small and unlikely to materially move the stock. Promoter holding remains well below the 50% majority threshold at 30.17%.